Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 6/20 | 0.40 |
| ▸ | RCOR1 | Q9UKL0 | 3/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL28134446 | 0.98 | MEN1 (0.59) | KMT2AMEN1NPC1GAAHTR2A | |
| SCHEMBL18926276 | 0.94 | NPC1 (0.55) | KMT2AMEN1NPC1GAAHTR2A | |
| SCHEMBL29116619 | 0.88 | HTR2A (0.50) | KMT2AMEN1NPC1GAAHTR2A | |
| SCHEMBL21174548 | 0.82 | MEN1 (0.43) | KMT2AMEN1NPC1GAAHTR2A | |
| SCHEMBL20869346 | 0.82 | MEN1 (0.43) | KMT2AMEN1NPC1GAAHTR2A | |
| SCHEMBL30441109 | 0.82 | MEN1 (0.43) | KMT2AMEN1NPC1GAAHTR2A | |
| SCHEMBL10042990 | 0.82 | CYP1A2 (0.50) | KMT2AMEN1NPC1GAAHTR2A | |
| SCHEMBL14804285 | 0.82 | MEN1 (0.50) | KMT2AMEN1NPC1GAAHTR2A | |
| SCHEMBL13805589 | 0.80 | MAPK1 (0.44) | KMT2AMEN1NPC1GAACYP1A2 | |
| SCHEMBL27880163 | 0.80 | KMT2A (0.46) | KMT2AMEN1NPC1GAAHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024110477-A2 | SYNTHESIS OF A CYCLIC PEPTIDE | JANSSEN PHARMACEUTICA NV (BE) | 2024-05-30 | — | — | WO | claimed |
| EP-4140988-A1 | L-VALINATE OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF | Merck Serono S.A. (CH) | 2023-03-01 | — | — | EP | claimed |
| EP-3400217-A1 | L-VALINATE OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF | Merck Serono S.A. (CH) | 2018-11-14 | — | — | EP | claimed |
| US-9834528-B2 | Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof | MERCK SERONO S.A. (CH) | 2017-12-05 | — | — | US | claimed |
| WO-2017118641-A1 | L-VALINATE OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF | MERCK SERONO S.A. (CH) | 2017-07-13 | — | — | WO | claimed |
| US-20170190677-A1 | ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF | MERCK SERONO S.A. (CH) | 2017-07-06 | — | — | US | claimed |
| WO-2016207626-A1 | FLUOROGENIC COMPOUNDS, PROCESS OF PREPARATION THEREOF AND METHODS OF USE | THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2016-12-29 | — | — | WO | claimed |
| EP-2914256-A1 | DISUBSTITUTED AMINO ACIDS AND METHODS OF PREPARATION AND USE THEREOF | Aileron Therapeutics, Inc. (US) | 2015-09-09 | — | — | EP | claimed |
| CN-104812384-A | Disubstituted amino acids and methods of preparation and use thereof | AILERON THERAPEUTICS INC | 2015-07-29 | — | — | CN | claimed |
| US-20140128581-A1 | DISUBSTITUTED AMINO ACIDS AND METHODS OF PREPARATION AND USE THEREOF | AILERON THERAPEUTICS, INC. (US) | 2014-05-08 | — | — | US | claimed |
| WO-2014071241-A1 | DISUBSTITUTED AMINO ACIDS AND METHODS OF PREPARATION AND USE THEREOF | AILERON THERAPEUTICS, INC. (US) | 2014-05-08 | — | — | WO | claimed |
| US-20240240114-A1 | Improved Combination of Protease and Protease Inhibitor with Secondary Enzyme | BASF SE (DE) | 2024-07-18 | — | — | US | disclosed |
| US-20240218014-A1 | SYNTHESIS OF A CYCLIC PEPTIDE | JANSSEN PHARMACEUTICA NV (BE) | 2024-07-04 | — | — | US | disclosed |
| WO-2024110477-A2 | SYNTHESIS OF A CYCLIC PEPTIDE | JANSSEN PHARMACEUTICA NV (BE) | 2024-05-30 | — | — | WO | disclosed |
| US-20240132808-A1 | Storage-Stable Hydrolase Containing Liquids | BASF SE (DE) | 2024-04-25 | — | — | US | disclosed |
| US-20130165539-A1 | ALKALINE-STABLE CHROMATOGRAPHIC RESINS | NORTH CAROLINA STATE UNIVERSITY (US) | 2013-06-27 | — | — | US | disclosed |
| US-20130146852-A1 | ORGANIC LIGHT-EMITTING POLYMER AND DEVICE | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2013-06-13 | — | — | US | disclosed |
| US-20130146852-A1 | ORGANIC LIGHT-EMITTING POLYMER AND DEVICE | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2013-06-13 | — | — | US | disclosed |
| WO-2002004543-A1 | COPOLYMER SEMI-CONDUCTOR MATERIALS MADE OF OLIGO-PHENYLENE UNITS AND AT LEAST ONE FLUORENE UNIT | SIEMENS AKTIENGESELLSCHAFT (DE) | 2002-01-17 | — | — | WO | disclosed |
| WO-2001056091-A2 | CHARGE TRANSPORT MATERIAL HAVING AN INCREASED GLASS TRANSITION TEMPERATURE AND THE USE OF SAID MATERIAL | SIEMENS AKTIENGESELLSCHAFT (DE) | 2001-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240218014-A1 | SYNTHESIS OF A CYCLIC PEPTIDE | VIP, QPCT, PTMS | KMT2A 4534/4885MEN1 361/4885NPC1 4023/4885 |
| US-20170190677-A1 | ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF | PGF, PTGER1, PTGFR | KMT2A 2719/4885MEN1 4686/4885NPC1 4121/4885 |
| US-20140128581-A1 | DISUBSTITUTED AMINO ACIDS AND METHODS OF PREPARATION AND USE THEREOF | ASNS, BCAT1, BCAT2 | KMT2A 2304/4885MEN1 1070/4885NPC1 2881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.